LOS ANGELES CAPITAL MANAGEMENT LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1177206
LOS ANGELES, CA
Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,854,978
+$1,648,328 QoQ
Shares Held
303,101
+913.5% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 172 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. VNDA ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in VNDA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,854,978 | 303,101 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $206,650 | 29,906 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,242 | 481 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $210,965 | 44,696 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $174,103 | 37,931 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,111,667 | 232,081 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,298,571 | 276,881 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,836,029 | 324,961 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,772,330 | 431,224 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $1,546,857 | 366,554 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,012,921 | 465,954 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,159,345 | 327,670 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,616,868 | 238,125 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $505,158 | 68,357 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $690,374 | 69,876 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $783,448 | 71,876 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $931,887 | 82,395 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,292,777 | 82,395 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,411,821 | 82,370 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,160,442 | 53,949 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 ALXN | — | 2,617 | Shares | Sole | 2021-05-05 | |
| 2021-03-31 | $911,398 | 60,679 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 ALXN | — | 2,617 | Shares | Sole | 2021-03-10 | |
| 2020-12-31 | $1,202,020 | 91,478 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 ALXN | — | 2,747 | Shares | Sole | 2020-11-02 | |
| 2020-09-30 | $895,510 | 92,703 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 ALXN | — | 41,129 | Shares | Sole | 2020-08-05 | |
| 2020-06-30 | $1,720,164 | 150,364 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 ALXN | — | 37,426 | Shares | Sole | 2020-05-04 | |
| 2020-03-31 | $2,192,507 | 211,632 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||